Medicament diffusing device

Abstract

Provided is a medicament diffusing device that improves operability when the inner container is relatively moved with respect to the outer container. The medicament diffusing device includes an inner container that houses a medicament diffusing body and an outer container that is disposed outside the inner container, the inner container has a button portion to which a pressing force is applied and an inner opening portion, the outer container has an outer opening portion that corresponds to the inner opening portion, the medicament diffusing device is configured so that the inner container can be relatively moved with respect to the outer container in a direction in which the pressing force applied to the button portion acts, and the medicament diffusing device is configured so that, when the inner container is relatively moved with respect to the outer container, the inner opening portion and the outer opening portion can be switched between a diffusing state in which at least a part of the inner opening portion and the outer opening portion overlap so that the inside of the inner container and the outside of the outer container communicate and a non-diffusing state in which the inner opening portion and the outer opening portion do not overlap at all so that the inside of the inner container and the outside of the outer container are blocked.

Description

Technical Field

[0001] This utility model relates to a drug evaporation device comprising a drug evaporator for evaporating a volatile drug, an inner container for containing the drug evaporator, and an outer container disposed outside the inner container. Background Technology

[0002] For example, a chemical vaporization device is used to make volatile agents such as fragrances, deodorants, repellents, and insecticides vaporize (see Patent Document 1).

[0003] Patent Document 1 discloses a drug evaporation device (sliding fragrance container) in which an inner box is inserted into an outer box, and is configured such that when the inner box is pulled out of the outer box by a predetermined size, the hole formed in the inner box coincides with the hole formed in the outer box, and the fragrance stored inside the inner box evaporates into the external gas.

[0004] Existing technical documents

[0005] Patent documents

[0006] Patent Document 1: Japanese Patent Application Publication No. 10-258116 Utility Model Content

[0007] The problem to be solved by utility models

[0008] In the pharmaceutical dispersing device described in Patent Document 1, when the inner box is pulled out from the outer box, for example, one hand holds the outer box, and the other hand grasps the upper and lower panels of the inner box, which are exposed from the cut-off portions formed at the center of the front edges of the upper and lower panels of the outer box, so that the inner box moves relative to the outer box in a pulling manner. Thus, in the pharmaceutical dispersing device described in Patent Document 1, it is impossible to move the inner box (inner container) relative to the outer box (outer container) without using both hands, so there is room for improvement in the operability of moving the inner box relative to the outer box.

[0009] This invention was made in view of the above-mentioned problems, and its purpose is to provide a drug evaporation device that improves operability when the inner container is moved relative to the outer container in a drug evaporation device configured to switch between a evaporation state and a non-evaporation state by moving the inner container relative to the outer container.

[0010] Solution for solving the problem

[0011] The present invention, which addresses the aforementioned problem, provides a pharmaceutical vaporization device comprising a pharmaceutical vaporizer for dispersing a volatile pharmaceutical agent, an inner container for containing the pharmaceutical vaporizer, and an outer container disposed outside the inner container.

[0012] Its features are,

[0013] The inner container has a button portion that can be pressed and an inner opening.

[0014] The outer container has an outer opening that corresponds to the inner opening.

[0015] The drug dispersing device is configured such that the inner container can move relative to the outer container in the direction of the pressing pressure applied to the button.

[0016] The drug dispersing device is configured such that, when the inner container is moved relative to the outer container, it can switch between a dispersing state in which the inner opening and the outer opening are at least partially overlapping, thus connecting the interior of the inner container to the exterior of the outer container, and a non-dispersing state in which the inner opening and the outer opening are completely non-overlapping, thus blocking the interior of the inner container from the exterior of the outer container.

[0017] According to the drug dispersing device of this structure, the inner container has a button portion to which pressure is applied, and the drug dispersing device is configured such that the inner container can move relative to the outer container in the direction of the pressure applied to the button portion. Furthermore, by moving the inner container relative to the outer container, a dispersing state is achieved where the inner and outer openings overlap at least partially, thus connecting the interior of the inner container to the exterior of the outer container, and a non-dispersing state is achieved where the inner and outer openings do not overlap completely, thus blocking the interior of the inner container from the exterior of the outer container. Thus, in a drug dispersing device configured to switch between a dispersing state and a non-dispersing state by moving the inner container relative to the outer container, for example, by applying pressure to the button portion with the index finger while grasping the outer container with the four fingers other than the index finger, the operation of moving the inner container relative to the outer container can be performed with one hand. Therefore, compared with conventional drug dispersing devices (Patent Document 1) that cannot move the inner container (inner box) relative to the outer container (outer box) without using both hands, the operability of moving the inner container relative to the outer container is improved.

[0018] In the pharmaceutical vaporization device of this invention, preferably,

[0019] The button portion includes:

[0020] A first button portion, which is concealed inside the outer container in the volatile state, and protrudes outward from the outer container in the non-volatile state; and

[0021] The second button protrudes outward from the outer container in the volatile state, and is hidden inside the outer container in the non-volatile state.

[0022] According to the drug dispersing device of this structure, the dispersing state is switched from non-dispersing to dispersing state by applying pressure to a first button protruding outward of the outer container when in the non-dispersing state. Conversely, the dispersing state is switched from dispersing to non-dispersing state by applying pressure to a second button protruding outward of the outer container when in the dispersing state. In this way, the dispersing and non-dispersing states can be easily switched by operating the first and second button portions.

[0023] In the pharmaceutical vaporization device of this invention, preferably,

[0024] The drug dispersing device includes a locking mechanism that locks the inner container and the outer container in relative positions when the inner container is in the dispersing state and / or the non-dispersing state.

[0025] According to the drug dispersing device of this structure, the inner container and the outer container are locked by a locking mechanism in the relative positions of the inner container and the outer container in the dispersing state and / or the non-dispersing state, thus stably maintaining the dispersing state and / or the non-dispersing state.

[0026] In the pharmaceutical vaporization device of this invention, preferably,

[0027] The drug dispersing device is provided with a sealing mechanism for preventing leakage of the volatile drug from between the inner container and the outer container in the non-dispersing state.

[0028] According to the pharmaceutical evaporation device of this structure, when in a non-evaporation state, the sealing mechanism can suppress the leakage of volatile pharmaceuticals between the inner and outer containers, thereby suppressing the wasteful consumption of volatile pharmaceuticals.

[0029] In the pharmaceutical vaporization device of this invention, preferably,

[0030] The outer opening includes an outer lower surface opening disposed opposite to the mounting surface on which the drug dispersing device is placed.

[0031] The inner opening includes an inner lower surface opening that corresponds to the outer lower surface opening.

[0032] According to the drug dispersing device of this structure, the volatile drug from the drug dispersant is dispersed from the inside of the inner container to the outside of the outer container through an inner opening including an inner lower surface opening and an outer opening including an outer lower surface opening. Therefore, the amount of drug dispersing can be increased and the drug dispersing area can be expanded.

[0033] In the pharmaceutical vaporization device of this invention, preferably,

[0034] The outer container has an opening and closing structure that allows the inner container to be partially opened and closed in a manner that enables entry and exit.

[0035] According to the drug dispersing device of this structure, the outer container has an opening and closing structure that partially opens and closes in a way that allows the inner container to enter and exit. Therefore, it is possible to improve the airtightness between the inner and outer containers while making it easier for the inner container to enter and exit relative to the outer container.

[0036] In the pharmaceutical vaporization device of this invention, preferably,

[0037] The drug dispersing device is configured to be able to be installed on the object to which the drug dispersing device is installed.

[0038] Even in situations where it is difficult to mount the drug dispersing device according to this structure, since the drug dispersing device is configured to be able to be installed on the installation object, it can also be used as an installation-type drug dispersing device.

[0039] In the pharmaceutical vaporization device of this invention, preferably,

[0040] The object to be installed is the sun visor installed inside a motor vehicle.

[0041] According to the structure of this pesticide dispersing device, it can be installed in the sun visor of a motor vehicle, thus enabling its use as a vehicle air freshener and insect repellent. Furthermore, compared to installation on the dashboard, this method avoids direct sunlight exposure, thus suppressing the effects of ultraviolet radiation and high temperatures. Consequently, it inhibits the deterioration of the raw materials constituting the pesticide dispersing device, the deterioration of the pesticide contained within the device, and also suppresses excessive pesticide dispersal. Moreover, compared to installation on the dashboard, it obstructs the driver's view less, thus offering significant safety advantages. Attached Figure Description

[0042] Figure 1 This is a perspective view of the maximum volatilization state of the drug volatilization device according to one embodiment of the present invention.

[0043] Figure 2 This is a perspective view of the non-volatile state of a drug volatile device according to one embodiment of the present invention.

[0044] Figure 3 It is a 3D view of the inner container.

[0045] Figure 4 This is an illustration of the internal structure of the drug volatilization device in both the maximum volatilization state and the non-volatilization state.

[0046] Figure 5 This is a perspective view of the drug volatilization device in its maximum volatilization state according to another embodiment 1 of this utility model.

[0047] Figure 6 This is a front view of the drug dispersing device of another embodiment 2 of this utility model.

[0048] Figure 7 This is an explanatory diagram of the drug volatilization device of another embodiment 3 of this utility model.

[0049] Explanation of reference numerals in the attached figures

[0050] 1. Drug volatilization device

[0051] 2. Pharmaceutical volatiles

[0052] 3. Inner container

[0053] 4. Outer container

[0054] 20 Inner opening

[0055] 24. Opening on the inner lower surface

[0056] 30 Button Section

[0057] 31 First button section

[0058] 32 Second button section

[0059] 50 Outer opening

[0060] 54. Opening on the lower outer surface

[0061] 61 First locking protrusion (locking mechanism)

[0062] 62 Second locking protrusion (locking mechanism)

[0063] 65 Outward-facing flange (sealing mechanism)

[0064] 71 First locking recess (locking mechanism)

[0065] 72 Second locking recess (locking mechanism)

[0066] 75. Inwardly facing flange (sealing mechanism)

[0067] 96. Sealing components (sealing mechanisms)

[0068] 98. Sealing components (sealing mechanisms). Detailed Implementation

[0069] The present invention will now be described with reference to the accompanying drawings. However, the present invention is not intended to be limited to the embodiments described below or the structures depicted in the drawings.

[0070] Figure 1 This is a perspective view of the maximum volatilization state of the drug volatilization device 1 according to one embodiment of the present invention. Figure 1 (a) is a top perspective view of the maximum evaporation state of the drug evaporation device 1 as seen from the front side. Figure 1 (b) is a bottom perspective view of the maximum evaporation state of the drug evaporation device 1 as observed from the rear side. Figure 2 This is a perspective view of the non-volatile state of the drug volatile device 1 according to one embodiment of the present invention. Figure 2 (a) is a top perspective view of the drug dispersing device 1 in its non-dispersing state, as seen from the front side. Figure 2 (b) is a bottom perspective view of the non-volatile state of the drug volatile device 1 as observed from the rear side. Figure 1 as well as Figure 2 The shown chemical dispersing device 1 is a placement type dispersing device suitable for use in rooms, entryways, etc. However, the use of the chemical dispersing device 1 is not limited to this placement type. For example, various types of chemical dispersing devices can be used, such as clamping type using clamps, suspension type using strips, adsorption type using magnets or suction cups, and anchoring type using fasteners.

[0071] <Overall Structure>

[0072] like Figure 1 As shown in (a) and (b), the drug dispersing device 1 includes a drug vapor 2 that holds a volatile drug in a dispersible state, an inner container 3 that contains the drug vapor 2, and an outer container 4 disposed outside the inner container 3 and containing the inner container 3. In the drug dispersing device 1, the inner container 3 and the outer container 4 form a nested structure (double structure) containing container 5. It should be noted that the inner container 3 and the outer container 4 constituting the containing container 5 can be manufactured, for example, using resin as a raw material and employing a known resin molding method such as injection molding, but are not limited thereto.

[0073] <Volatile Agents>

[0074] Volatile pesticides can be used alone or in combination with insecticides, fragrances, deodorizers, mildew inhibitors, and antibacterial agents, but are not particularly limited in their application. For example, when used to repel or control flying pests such as mosquitoes, midges, and moth flies, pyrethroid compounds are preferred as volatile pesticides. In particular, room-temperature volatile pyrethroid compounds such as methoxyfenozide, propofol, fenpyrethrin, and tetrafluorobenzyl are suitable due to their high volatility and control efficacy against flying pests. It should be noted that various optical or geometric isomers exist for these volatile pyrethroid compounds, but any isomer can be used. Furthermore, various additives can be used, or they can be used in combination with known non-volatile pesticides.

[0075] Examples of aromatic compounds that can be cited as fragrance agents include, for example, orange oil, lemon oil, lavender oil, peppermint oil, eucalyptus oil, lemon eucalyptus oil, citronella oil, lime oil, grapefruit oil, jasmine oil, cypress oil, green tea essential oil, peppermint oil, menthol, menthyl acetate, limonene, α-pinene, linalool, geraniol, phenethyl alcohol, pentyl cinnamaldehyde, cuminaldehyde, terpineol, and benzyl acetate, as well as fragrance compounds containing quinol and / or quinolaldehyde, often referred to as "green leaf volatiles." These fragrance agents can be used alone or in combination.

[0076] Examples of deodorizing agents include, for instance, green tea extract and persimmon extract, which are plant extracts, as well as cypress oil, juniper oil, bamboo extract, artemisia extract, tung oil, ethyl pyruvate, phenyl pyruvate, and other pyruvate esters. These deodorizing agents can be used alone or in combination. Additionally, deodorizing agents formed from porous materials such as activated carbon and zeolite can be used, and items obtained by processing deodorizing agents containing metal ions such as silver, copper, and zinc, or titanium dioxide photocatalysts, into plates, granules, or flakes, and then loading volatile deodorizing agents onto them.

[0077] Examples of antifungal agents include 2-octyl-4-isothiazolin-3-one, 5-chloro-2-methyl-4-isothiazolin-3-one, 3-methyl-4-isopropylphenol, p-chloro-m-xylenol, o-phenylphenol, N-(fluorodichloromethylthio)-phthalimide, juniper alcohol, thymol, tetrahydrolinalool, carvacrol, etc. These antifungal agents can be used alone or in combination.

[0078] Examples of antibacterial agents include, for example, juniper alcohol, tetrahydrolinalool, eugenol, citronellol, allyl isothiocyanate, carvone, pinene, terpene alcohol, 3-methyl-4-isopropylphenol, thymol, and carvacrol. These antibacterial agents can be used alone or in combination.

[0079] <Pharmaceutical volatiles>

[0080] As the volatile component 2, for example, a volatile component composed of a volatile agent that is retained in a volatile state through impregnation, internal addition, etc., can be used. Examples of raw materials for the volatile component 2 include paper, pulp, natural fibers, synthetic fibers, resin bodies, resin sheets, inorganic / organic porous bodies, gels, etc. While impregnating the resin sheet with the agent is a simple method for retaining the agent in the volatile component 2, a resin with an internally added volatile agent is preferred from the perspectives of easily controlling the sustained release of the volatile agent during use, ensuring stable volatile agent release, and suppressing agent loss due to moisture such as rain, but this is not particularly limiting. Examples of resins used as resin bodies and resin sheets include polyethylene, polypropylene, polyvinyl alcohol, polyvinyl acetate, polybutadiene, polyisoprene, ethylene-vinyl acetate copolymer, ethylene-methyl methacrylate copolymer, styrene-butadiene copolymer, etc. The morphology of the drug volatile 2 is not particularly limited to flakes, granules, three-dimensional forms, etc., but from the viewpoint of improving the volatilization efficiency of volatile drugs, honeycomb structures, open-pore structures, planar or three-dimensional mesh structures can be adopted, for example.

[0081] <Inner Container>

[0082] Figure 3 This is a three-dimensional view of the inner container 3. Figure 3 (a) is a perspective view of the inner container 3 from the front side. Figure 3 (b) is a perspective view of the inner container 3 from the rear side. Figure 3 As shown in (a) and (b), the inner container 3 has an inner container body 10 and a button portion 30 to which pressure is applied.

[0083] The inner container body 10 includes an inner front portion 11 constituting the front portion, an inner back portion 12 constituting the back portion, an inner upper surface portion 13 constituting the upper surface portion, an inner lower surface portion 14 constituting the lower surface portion, an inner right surface portion 15 constituting the right side portion, and an inner left surface portion 16 constituting the left side portion. In the inner container body 10, the adjacent surfaces of the inner front portion 11, inner back portion 12, inner upper surface portion 13, inner lower surface portion 14, inner right surface portion 15, and inner left surface portion 16 are integrally connected to each other and formed into a hexahedron shape with a longer main view rectangle in the left-right direction.

[0084] <Inner opening>

[0085] On the inner front portion 11, a plurality of (three in this example) inner front openings 21, each elongated in the vertical direction and rectangular in shape, are formed at predetermined intervals along the left-right direction. On the inner back portion 12, a plurality of (three in this example) inner back openings 22, each elongated in the vertical direction and rectangular in shape, are formed at predetermined intervals along the left-right direction, corresponding to the plurality of inner front portions 21. On the inner upper surface portion 13, a plurality of (three in this example) inner upper surface openings 23, each elongated in the left-right direction and rectangular in shape, are formed at predetermined intervals along the left-right direction. On the inner lower surface portion 14, a plurality of (three in this example) inner lower surface openings 24, each elongated in the left-right direction and rectangular in shape, are formed at predetermined intervals along the left-right direction, corresponding to the plurality of inner upper surface openings 23. The "inner opening" in this invention includes the inner front opening 21, the inner back opening 22, the inner upper surface opening 23, and the inner lower surface opening 24. In the following description, these openings 21 to 24 are sometimes collectively referred to as inner openings 20, as needed.

[0086] <Button Section>

[0087] The button section 30 includes a first button section 31 and a second button section 32. The first button section 31 is provided in a rectangular block shape protruding to the right from the center of the right inner surface section 15 of the inner container body 10 in the vertical direction. The first button section 31 is positioned in the maximum evaporation state (refer to...). Figure 1 (a) is hidden inside the outer container 4 when it is in a non-volatile state (see (a)). Figure 2 (a) The amount of protrusion from the inner right surface portion 15 is set in such a way that it protrudes outward from the outer container 4. The second button portion 32 is provided in a rectangular block shape protruding to the left from the center of the inner left surface portion 16 in the vertical direction of the inner container body 10. The second button portion 32 is designed to be in the maximum evaporation state (refer to Figure 1 (b) When it protrudes to the outside of the outer container 4, on the other hand, in the non-volatile state (refer to...) Figure 2 (b) The amount of protrusion from the inner left surface portion 16 is set in such a way that it is hidden inside the outer container 4. It should be noted that the shape of the button portion 30 is not limited to a rectangular block shape, for example, it can also be cylindrical or crescent-shaped (see [reference]). Figure 6 ), wave shape. In addition, the first button part 31 and the second button part 32 can be set to different shapes and colors respectively. In this case, it is preferable to set the shape and color of the first button part 31 and the second button part 32 in a way that makes it easy for the user to identify the usage state (on (evaporation state) / off (non-evaporation state)).

[0088] In this embodiment, the inner container 3 is configured such that, when the orientation of the inner front portion 11 and the inner back portion 12 is set to the front-rear direction, the inner container 3 can be divided into two parts in the front-rear direction, namely, a front-side container portion 3a constituting half of the front side and a back-side container portion 3b constituting half of the back side (the lines indicating the division position are omitted from the illustration), and is assembled by locking the two container portions 3a and 3b with the drug vapor 2 sandwiched between them using a known locking mechanism (not shown).

[0089] <Outer Container>

[0090] like Figure 1 As shown in (a) and (b), the outer container 4 includes an outer front portion 41 constituting the front portion, an outer back portion 42 constituting the back portion, an outer upper surface portion 43 constituting the upper surface portion, and an outer lower surface portion 44 constituting the lower surface portion. In this outer container 4, the adjacent surfaces of the outer front portion 41, outer back portion 42, outer upper surface portion 43, and outer lower surface portion 44 are integrally connected to each other and formed into a quadrangular cylindrical shape with a long main view rectangle in the left-right direction and a hollow portion with an opening in the left-right direction. The outer front portion 41, outer back portion 42, outer upper surface portion 43, and outer lower surface portion 44 of the outer container 4 are respectively opposite to the inner front portion 11, inner back portion 12, inner upper surface portion 13, and inner lower surface portion 14 of the inner container 3 disposed inside the outer container 4. In this embodiment, the outer container 4 is configured such that, when the direction in which the outer front portion 41 and the outer back portion 42 are arranged is set to the front-rear direction, the outer container 4 can be divided into two parts in the front-rear direction, namely, a front-side container portion 4a constituting half of the front side and a back-side container portion 4b constituting half of the back side (the lines indicating the division position are omitted from the illustration), and is assembled by locking the inner container 3 between the two container portions 4a and 4b in a manner that allows it to move in the left-right direction using a known locking mechanism (not shown).

[0091] <Outer opening>

[0092] On the outer front face portion 41, a plurality of rectangular openings 51 (three in this example) that are longer in the vertical direction are formed at predetermined intervals along the left-right direction, corresponding to a plurality of inner front face openings 21. On the outer back face portion 42, a plurality of rectangular openings 52 (three in this example) that are longer in the vertical direction are formed at predetermined intervals along the left-right direction, corresponding to a plurality of inner back face openings 22. On the outer upper surface portion 43, a plurality of rectangular openings 53 (three in this example) that are longer in the left-right direction are formed at predetermined intervals along the left-right direction, corresponding to a plurality of inner upper surface openings 23. On the outer lower surface portion 44, a plurality of rectangular openings 54 (three in this example) that are longer in the left-right direction are formed at predetermined intervals along the left-right direction, corresponding to a plurality of inner lower surface openings 24. The "outer opening" in this utility model includes an outer front opening 51, an outer back opening 52, an outer upper surface opening 53, and an outer lower surface opening 54. In the following description, as needed, these openings 51 to 54 are sometimes collectively referred to as the outer opening 50.

[0093] At both ends of the outer lower surface portion 44 in the outer container 4, a pair of legs 55 are provided protruding downwards. In the drug dispersing device 1 of this embodiment, by providing a pair of protruding legs 55, a lower surface side flow path 56 is formed between the mounting surface on which the drug dispersing device 1 is mounted and the outer lower surface portion 44, which leads to the outside of the outer container 4 via a plurality of outer lower surface openings 54 disposed facing the mounting surface.

[0094] In the drug dispersing device 1 of this embodiment, the inner container 3 is inserted into the hollow portion of the outer container 4 such that the inner container 3 can move relative to the outer container 4 in the direction (left-right direction) of the pressing pressure applied to the first button portion 31 and the second button portion 32. Furthermore, when the inner container 3 moves relative to the outer container 4, the inner opening portion 20 and the outer opening portion 50 can be switched to a dispersing state where the inner container 3 and the outer container 4 are at least partially overlapping, thus communicating between the interior of the inner container 3 and the exterior of the outer container 4 (refer to the maximum dispersing state). Figure 1 The inner container 3 and the outer container 4 are in a state where they do not overlap, thus blocking the interior of the inner container 3 from the exterior of the outer container 4 (see reference). Figure 2 ).

[0095] <Card-stopping mechanism>

[0096] Figure 4 This is an illustration of the internal structure of the drug volatilization device 1 in both the maximum volatilization state and the non-volatilization state. Figure 4(a) shows the internal structure of the drug volatilization device 1 in its maximum volatilization state, and is Figure 1 (a) AA-direction sectional view. Figure 4 (b) shows the internal structure of the drug volatilization device 1 in a non-volatile state, and is Figure 2 (a) BB-direction sectional view. For example... Figure 4 As shown in (a) and (b), on the inner upper surface portion 13 and inner lower surface portion 14 of the inner container 3, a pair of first locking protrusions 61 and a pair of second locking protrusions 62 in the vertical direction are provided at predetermined intervals in the relative movement direction (left-right direction) of the inner container 3 relative to the outer container 4. Figure 4 As shown in (a), on the outer upper surface portion 43 and outer lower surface portion 44 of the outer container 4, a pair of first locking recesses 71 are formed, which engage with a pair of first locking protrusions 61 when the relative positions of the inner container 3 and the outer container 4 are in the maximum evaporation state of the drug evaporation device 1. Figure 4 As shown in (b), on the outer upper surface portion 43 and outer lower surface portion 44 of the outer container 4, a pair of second locking recesses 72 are formed, which engage with a pair of second locking protrusions 62 when the relative positions of the inner container 3 and the outer container 4 are in a non-volatile state of the drug evaporation device 1. The structure including the aforementioned first locking protrusion 61, first locking recess 71, second locking protrusion 62 and second locking recess 72 is equivalent to the "locking mechanism" of this utility model.

[0097] <Sealing Mechanism>

[0098] like Figure 4 As shown in (a) and (b), at the left and right ends of the inner container 3, a pair of outwardly projecting flanges 65 are positioned such that the inner openings 20 (inner front opening 21, inner back opening 22, inner upper surface opening 23, and inner lower surface opening 24) are sandwiched in the middle in the left-right direction. Figure 3 It forms a continuous ring shape. For example... Figure 4 As shown in (b), in the outer container 4, the inner container 3 (where the drug dispersion device 1 is in a non-volatile state) and the outer container 4, a pair of inwardly facing flanges 75, which are close to a pair of outwardly facing flanges 65, are formed in a continuous ring on the entire surface of the outer front portion 41, the outer upper surface portion 43, the outer back portion 42, and the outer lower surface portion 44. Thus, between the inner container 3 and the outer container 4, the drug dispersion device 1... Figure 4In the non-volatile state shown in (b), the pair of outwardly facing flanges 65 and the pair of inwardly facing flanges 75 form a tortuous path. Thus, the pair of outwardly facing flanges 65 and the pair of inwardly facing flanges 75 can function as a labyrinth seal 80 (equivalent to the "sealing mechanism" of this invention).

[0099] In the drug vaporization device 1 constructed as described above, in Figure 2 In the non-volatile state shown in (a) and (b), for example, by grasping the outer container 4 with the four fingers other than the index finger, applying pressure to the first button portion 31 protruding outward from the outer container 4 with the index finger, thereby releasing... Figure 2 The non-volatile state shown in (a) and (b) is switched to Figure 1 The maximum evaporation state as shown in (a) and (b).

[0100] From Figure 4 The non-volatile state shown in (b) is directed towards Figure 4 In the intermediate state (vaporization state) of the maximum volatile state switching shown in (a), the inner opening 20 and the outer opening 50 partially overlap, the interior of the inner container 3 is connected to the exterior of the outer container 4, and the volatile agent is volatile according to the size of the area (ventilation area) of the overlap between the inner opening 20 and the outer opening 50.

[0101] From Figure 4 The non-volatile state shown in (b) is directed towards Figure 4 During the switching of the maximum evaporation state shown in (a), while the inner container 3 moves relative to the outer container 4 by applying pressure to the first button 31, the dynamic friction between the outward flange 65 and the locking protrusions 61, 62 provided in the inner container 3 and the inner circumferential surface of the outer container 4 becomes a moderate resistance. Therefore, the relative position of the inner container 3 to the outer container 4 can be easily adjusted steplessly. As a result, the ventilation area can be easily adjusted steplessly. Afterward, when the pressure on the first button 31 is stopped, the ventilation area remains the same as when the pressure on the first button 31 was stopped due to the static friction between the outward flange 65 and the locking protrusions 61, 62 provided in the inner container 3 and the inner circumferential surface of the outer container 4, thus the amount of volatile agent evaporation can be easily adjusted.

[0102] And, as Figure 4As shown in (a), when switching to the maximum evaporation state where the overlapping area of ​​the inner opening 20 and the outer opening 50 is maximized, a pair of first locking protrusions 61 and a pair of first locking recesses 71 engage at the relative positions of the inner container 3 and the outer container 4 in the maximum evaporation state of the drug evaporation device 1. Thus, the inner container 3 and the outer container 4 are locked by the pair of first locking protrusions 61 and the pair of first locking recesses 71, and the maximum evaporation state is stably maintained. In this maximum evaporation state, the volatile drug is evaporated to the maximum extent.

[0103] In the drug dispersing device 1, volatile drug from the drug dispersant 2 flows from the inside of the inner container 3 through the opening 23 on the inner upper surface (see reference). Figure 3 (a) and the inner lower surface opening 24 (see reference) Figure 3 (b)) The inner opening 20 and the outer upper surface opening 53 (see reference) Figure 1 (a) and the opening 54 on the outer lower surface (see reference) Figure 1 The drug can be dispersed to the outside of the outer container 4 through the outer opening 50 of (b), thus increasing the amount of drug dispersion and expanding the drug dispersion area.

[0104] exist Figure 1 In the case of the maximum evaporation state shown in (a), for example, by grasping the outer container with the four fingers other than the index finger, applying pressure to the second button portion 32 protruding outward from the outer container 4 with the index finger, thereby releasing the evaporation from the outer container 4. Figure 1 The maximum evaporation state shown in (a) switches to Figure 2 The non-volatile state shown in (a). At this time, as Figure 4 As shown in (b), when the drug dispersing device 1 is in a non-dispersible state, a pair of second locking protrusions 62 and a pair of second locking recesses 72 engage with each other at their relative positions. Thus, the inner container 3 and the outer container 4 are locked by the pair of second locking protrusions 62 and the pair of second locking recesses 72, and the non-dispersible state is stably maintained. In this non-dispersible state, the inner opening 20 and the outer opening 50 are completely non-overlapping, and the interior of the inner container 3 and the exterior of the outer container 4 are blocked.

[0105] exist Figure 4 In the non-volatile state shown in (b), under the action of the labyrinth seal 80 composed of a pair of outwardly facing flanges 65 and a pair of inwardly facing flanges 75, the leakage of volatile agent from the gap between the inner container 3 and the outer container 4 can be suppressed when the agent volatile device 1 is in the non-volatile state.

[0106] In the drug dispersing device 1 of this embodiment, the operation of moving the inner container 3 relative to the outer container 4 can be performed using only one hand. Therefore, compared with conventional drug dispersing devices (Patent Document 1) that cannot move the inner container 3 (inner box) relative to the outer container 4 (outer box) without using both hands, the operability of moving the inner container 3 relative to the outer container 4 is improved.

[0107] The above description of the pharmaceutical vaporization device 1 of this utility model is based on one embodiment. However, this utility model is not limited to the structure described in the above embodiment, and its structure can be appropriately modified without departing from its spirit. Other specific embodiments are as follows.

[0108] (Other implementation method 1)

[0109] Figure 5 This is a perspective view of the pharmaceutical evaporation device 1A in its maximum evaporation state according to another embodiment 1 of this utility model. Figure 5 In the drug dispersing device 1A shown, the outer container 4 includes: a container body 90, which is a four-cornered cylindrical shape with an outer front portion 41, an outer back portion 42, an outer upper surface portion 43 and an outer lower surface portion 44, open in the left and right direction; a first cover member 91, which opens and closes one opening of the container body 90; and a second cover member 92, which opens and closes the other opening of the container body 90.

[0110] The first cover member 91 has a first insertion hole 91a through which the first button part 31 can be inserted, and is mounted to the container body 90 via a hinge member 95, allowing one opening of the outer container 4 to be opened and closed. With one opening of the container body 90 closed, the first cover member 91 inserts the first button part 31 through the first insertion hole 91a. Between the periphery of the first insertion hole 91a and the outer peripheral surface of the first button part 31, for example, a sealing member 96 (equivalent to the "sealing mechanism" of this invention) made of sponge material with independent air bubbles is sandwiched.

[0111] The second cover member 92 has a second through hole 92a through which the second button portion 32 can be inserted, and can be mounted to the container body 90 with the other opening of the outer container 4 openable and closable via a hinge member 97. Similarly, with the second cover member 92 closed, the second button portion 32 is inserted through the second through hole 92a. A sealing member 98 (equivalent to the "sealing mechanism" of this invention) is sandwiched between the periphery of the second through hole 92a and the outer peripheral surface of the second button portion 32.

[0112] According to the drug dispersing device 1A of other embodiment 1, the outer container 4 has a container body 90 and a cover member 91, 92 for opening and closing the opening of the container body 90, and has an opening and closing structure in which a portion (cover member 91, 92) is opened and closed so that the inner container 3 can enter and exit. Therefore, by closing the cover member 91, 92, the airtightness between the inner container 3 and the outer container 4 can be improved, thereby eliminating the labyrinth seal 8 in the above embodiment, and by opening the cover member 91, 92, the inner container 3 can easily enter and exit relative to the outer container 4.

[0113] (Other implementation method 2)

[0114] Figure 6 This is a front view of the drug dispersing device 1B of another embodiment 2 of this utility model. Figure 6 (a) is a diagram showing the maximum evaporation state. Figure 6 (b) is a diagram showing the non-volatile state. Figure 6 In the drug dispersing device 1B shown in (a) and (b), the outer container 4 includes: an outer container body 100, which is formed into a rectangular shape that is longer in the vertical direction and has a hollow part with an opening in the vertical direction; and a pair of end structures 101, which are respectively connected to one end side (upper end side) and the other end side (lower end side) of the outer container body 100.

[0115] like Figure 6 As shown in (a) and (b), a pair of end structures 101 respectively constitute the upper and lower parts of the outer container 4 when the drug dispersing device 1B is mounted on the mounting surface FL of the drug dispersing device 1B. In the pair of end structures 101, in Figure 6 The maximum evaporation state shown in (a) and Figure 6 In the non-volatile state shown in (b), the end structure 101 constituting the lower part of the outer container 4 functions as a pedestal for placing the drug volatile device 1B, thereby improving the stability of the placement state.

[0116] In the drug dispersing device 1B, the inner container 3 is inserted into the hollow portion of the outer container 4 such that the inner container 3 can move relative to the outer container 4 in the direction (vertical direction) of the pressing pressure applied to the crescent-shaped first button portion 31 and second button portion 32. The first button portion 31 is located in... Figure 6 As shown in (a), during the maximum evaporation state, it is hidden inside the outer container 4. On the other hand, in Figure 6 In the non-volatile state shown in (b), it protrudes outward (upward) from the outside of the outer container 4, and the second button part 32 is... Figure 6As shown in (a), at the maximum evaporation state, it protrudes to the outside (above) of the outer container 4; on the other hand, in Figure 6 In the non-volatile state shown in (b), it is hidden inside the outer container 4.

[0117] In the drug vaporization device 1B constructed as described above, in Figure 6 In the non-volatile state shown in (b), when the outer container 4 is tilted in an upside-down manner and the drug volatile device 1B is placed on the mounting surface FL, the drug volatile device 1B is placed on the mounting surface FL. Figure 6 In the non-volatile state shown in (b), pressure is applied to the first button portion 31 protruding outward (upward). Thus, from... Figure 6 The non-volatile state shown in (b) is switched to Figure 6 The maximum evaporation state as shown in (a).

[0118] In the drug vaporization device 1B, Figure 6 In the case of the maximum evaporation state shown in (a), when the outer container 4 is overturned in an upside-down manner and the drug evaporation device 1B is placed on the mounting surface FL, the evaporation device 1B is released from the mounting surface FL onto the drug in the following situation: Figure 6 In the maximum evaporation state shown in (a), pressure is applied to the second button portion 32 protruding outward (upward). Thus, from... Figure 6 The maximum evaporation state shown in (a) switches to Figure 6 The non-volatile state shown in (b).

[0119] In this way, by simply flipping the outer container 4 upside down to place the drug dispersing device 1B on the mounting surface FL, switching can be easily achieved. Figure 6 The maximum volatile state shown in (a) is similar to Figure 6 The non-volatile state shown in (b).

[0120] (Other implementation method 3)

[0121] In the above embodiments and other embodiments 1 and 2, examples are shown of using the drug dispersing devices 1, 1A, and 1B in an upright state, but they can also be used in a laid-down state.

[0122] Figure 7 This is an explanatory diagram of the drug volatilization device 1 in another embodiment 3 of this utility model. Figure 7 (a) is a perspective view of the drug dispersing device 1 with linear protrusions 110 in its maximum dispersal state. Figure 7 (b) is a state diagram showing the use of the drug dispersing device 1 with the outer front part 41 facing the mounting surface FL, with the device lying down and having the linear protrusion 110 facing each other.

[0123] like Figure 7 As shown in (a), a pair of protrusions 110 are provided on the outer front surface 41 of the outer container 4. The pair of protrusions 110 are arranged in a trapezoidal cross-section between the plurality of outer front openings 51 in the outer front surface 41 and the left and right side edges, extending linearly in the vertical direction when the drug dispersing device 1 is in an upright position. The protrusions 110 can be integrally formed on the outer container 4 during the resin molding process, or by attaching separately molded cushioning rubber or the like to the outer container 4. Figure 7 As shown in (b), a pair of protrusions 110 are also provided on the outer back side portion 42 of the outer container 4.

[0124] In the drug dispersing device 1 of other embodiments 3, which have the protrusions 110 as described above, such as Figure 7 As shown in (b), when the drug dispersing device 1 is used with the outer front portion 41 facing the mounting surface FL, a pair of protrusions 110 are located between the outer front portion 41 and the mounting surface FL. Therefore, in the dispersing state (maximum dispersing state in this example), a flow is formed from the inside of the inner container 3 through the inner front portion 21 (see Figure 1). Figure 7 (a) and the outer front opening 51 (see reference) Figure 7 (a) and leads to the bottom flow path Q outside the outer container 4. Thus, as Figure 7 As shown in (b), even when the drug dispersing device 1 is used in a folded position, it is possible to prevent the inner opening 20 (inner front part 21; see reference FL) opposite the mounting surface FL from being obstructed. Figure 7 (a) and the outer opening 50 (outer front opening 51; see reference) Figure 7 (a) is blocked by the mounting surface FL, and the volatile agent from the agent volatile body 2 flows through the bottom flow path Q from the inside of the inner container 3 to the outside of the outer container 4, causing the volatile agent to evaporate to the outside of the outer container 4. It should be noted that although detailed descriptions based on the illustrations are omitted, even when compared with... Figure 7 When the drug dispersing device 1 is used in the manner shown in (b) with the top and bottom reversed and the outer back part 42 facing the mounting surface FL, a pair of protrusions 110 are located between the outer back part 42 and the mounting surface FL, thus forming a bottom flow path Q that is the same as the bottom flow path Q described above, and also preventing the inner opening 20 (inner back opening 22) facing the mounting surface FL. Figure 1 (b) and the outer opening 50 (outer dorsal opening 52); Figure 1 (b) is blocked by the surface FL, which allows volatile agents to evaporate to the outside of the outer container 4.

[0125] Figure 7 (c) is a perspective view of the drug dispersing device 1 with dotted protrusions 120 in its maximum dispersal state. Figure 7 (d) is a state diagram showing the use of the drug dispersing device 1 with dotted protrusions 120 laid down with the outer front part 41 facing the mounting surface FL.

[0126] like Figure 7 As shown in (c), four truncated conical protrusions 120 are provided near the four corners of the outer front portion 41 of the outer container 4. Like the aforementioned protrusions 110, the protrusions 120 can be integrally formed during the resin molding of the outer container 4, or by attaching separately molded cushioning rubber or the like to the outer container 4. Figure 7 As shown in (d), four protrusions 120 are also provided on the outer back portion 42 of the outer container 4 (in Figure 7 (d) only shows the two visible from the reader's side.

[0127] In the drug dispersing device 1 of other embodiments 3, which have the protrusions 120 as described above, such as Figure 7 As shown in (d), when the drug dispersing device 1 is laid down and used with the outer front portion 41 facing the mounting surface FL, the four protrusions 120 are located between the outer front portion 41 and the mounting surface FL. Therefore, in the dispersing state (maximum dispersing state in this example), a flow is formed from the inside of the inner container 3 through the inner front portion 21 (see Figure 3). Figure 7 (c) and the outer front opening 51 (see reference) Figure 7 (c) and leads to the bottom flow path Q outside the outer container 4. Thus, as Figure 7 As shown in (d), even when the drug dispersing device 1 is used in a horizontal position, it is possible to prevent the inner opening 20 (inner front part 21; see reference FL) opposite the mounting surface FL from being obstructed. Figure 7 (c) and the outer opening 50 (outer front opening 51; see reference) Figure 7 (c) is blocked by the mounting surface FL, and the volatile agent from the agent volatile body 2 flows through the bottom flow path Q from the inside of the inner container 3 to the outside of the outer container 4, thereby enabling the volatile agent to evaporate to the outside of the outer container 4. It should be noted that although detailed descriptions based on the illustrations are omitted, even when compared with... Figure 7In the usage shown in (d), when the drug dispersing device 1 is used with the top and bottom reversed and the outer back portion 42 facing the mounting surface FL, the four protrusions 120 are located between the outer back portion 42 and the mounting surface FL, thus forming a bottom flow path Q that is the same as the bottom flow path Q described above. This also prevents the inner opening 20 (inner back opening 22; see reference) facing the mounting surface FL from being blocked. Figure 1 (b) and the outer opening 50 (outer dorsal opening 52; see reference) Figure 1 (b) is blocked by the surface FL, which allows volatile agents to evaporate to the outside of the outer container 4.

[0128] (Other implementation method 4)

[0129] In the above embodiments and other embodiments 1 to 3, examples are shown of using the drug dispersing devices 1, 1A, and 1B in a state of being placed on a mounting surface. However, the drug dispersing devices can also be used in a state of being installed on an object. For example, it is possible to consider installing the drug dispersing devices on the wall of a room or suspending them from the ceiling. In this case, the wall or ceiling of the room becomes the object on which the drug dispersing devices are installed. If the drug dispersing devices are installed in this way, even in situations where there is insufficient space on the floor, table, or other surfaces to place the drug dispersing devices, the drug dispersing devices can still be used in the processing space.

[0130] Installable pesticide diffusers are particularly useful when used on sun visors installed inside motor vehicles. In their normally non-use state, the sun visor is located directly below the roof, behind the windshield of the vehicle. Therefore, for example, a clamp (which can be a hook-shaped component) can be attached to the outer container of the pesticide diffuser, and this clamp can be used to hold the pesticide diffuser to the sun visor. In this case, the pesticide diffuser can be used as a vehicle-mounted air freshener or insect repellent.

[0131] In this way, installing the drug dispersing device on the sun visor, compared to installing it on the dashboard or similar surface, prevents direct sunlight exposure and thus suppresses the effects of ultraviolet radiation and high temperatures. As a result, it inhibits the deterioration of the raw materials constituting the drug dispersing device and the drug contained within it, thereby also suppressing excessive drug dispersal. Furthermore, compared to installing it on the dashboard or similar surface, it obstructs the driver's view less, thus offering greater safety advantages.

[0132] Industrial applicability

[0133] The chemical dispersing device of this invention can be used not only as a dispersing device for fragrances and deodorizers, but also as an effective means of repelling or avoiding flying pests such as mosquitoes, midges, and moth flies, as well as mites and creeping pests.

Claims

1. A drug vaporization device comprising a drug vapor body for vaporizing a volatile drug, an inner container for containing the drug vapor body, and an outer container disposed outside the inner container. Its features are, The inner container has a button portion that can be pressed and an inner opening. The outer container has an outer opening that corresponds to the inner opening. The drug dispersing device is configured such that the inner container can move relative to the outer container in the direction of the pressing pressure applied to the button. The drug dispersing device is configured such that, when the inner container is moved relative to the outer container, it can switch between a dispersing state in which the inner opening and the outer opening are at least partially overlapping, thus connecting the interior of the inner container to the exterior of the outer container, and a non-dispersing state in which the inner opening and the outer opening are completely non-overlapping, thus blocking the interior of the inner container from the exterior of the outer container.

2. The drug vaporization device according to claim 1, characterized in that, The button portion includes: A first button portion, which is concealed inside the outer container in the volatile state, and protrudes outward from the outer container in the non-volatile state; and The second button protrudes outward from the outer container in the volatile state, and is hidden inside the outer container in the non-volatile state.

3. The drug vaporization device according to claim 1 or 2, characterized in that, The drug dispersing device includes a locking mechanism that locks the inner container and the outer container in relative positions when the inner container is in the dispersing state and / or the non-dispersing state.

4. The drug vaporization device according to claim 1 or 2, characterized in that, The drug dispersing device is provided with a sealing mechanism for preventing leakage of the volatile drug from between the inner container and the outer container in the non-dispersing state.

5. The drug vaporization device according to claim 1 or 2, characterized in that, The outer opening includes an outer lower surface opening disposed opposite to the mounting surface on which the drug dispersing device is placed. The inner opening includes an inner lower surface opening that corresponds to the outer lower surface opening.

6. The drug vaporization device according to claim 1 or 2, characterized in that, The outer container has an opening and closing structure that allows the inner container to be partially opened and closed in a manner that enables entry and exit.

7. The pharmaceutical vaporization device according to claim 1 or 2, characterized in that, The drug dispersing device is configured to be able to be installed on the object to which the drug dispersing device is installed.

8. The pharmaceutical vaporization device according to claim 7, characterized in that, The object to be installed is the sun visor installed inside a motor vehicle.

Images